Targeted therapy in antiphospholipid syndrome

S Sciascia, MA Khamashta… - Current opinion in …, 2014 - journals.lww.com
Antiphospholipid syndrome is an autoimmune disease characterized by thrombosis and
pregnancy morbidity occurring in patients persistently positive for aPL. Current therapeutic …
被引用次数：28 相关文章
[PDF] unito.it

[PDF][PDF] Targeted therapy in antiphospholipid syndrome

S Sciascia, MA Khamashta, DP D'Cruz - CURRENT OPINION IN …, 2014 - iris.unito.it
Purpose of review: To review novel therapeutic targets that are currently under investigation
to develop safer, targeted therapies for antiphsopholipid antibody (aPL)-mediated clinical …

Targeted therapy in antiphospholipid syndrome

S Sciascia, MA Khamashta… - Current opinion in …, 2014 - pubmed.ncbi.nlm.nih.gov
Purpose of review To review novel therapeutic targets that are currently under investigation
to develop safer, targeted therapies for antiphsopholipid antibody (aPL)-mediated clinical …

Targeted therapy in antiphospholipid syndrome.

S Sciascia, MA Khamashta… - Current Opinion in …, 2014 - europepmc.org
Antiphospholipid syndrome is an autoimmune disease characterized by thrombosis and
pregnancy morbidity occurring in patients persistently positive for aPL. Current therapeutic …

Targeted therapy in antiphospholipid syndrome

S Sciascia, MA Khamashta, D D'Cruz - Current Opinion in …, 2014 - kclpure.kcl.ac.uk
Antiphospholipid syndrome is an autoimmune disease characterized by thrombosis and
pregnancy morbidity occurring in patients persistently positive for aPL. Current therapeutic …